Nuveen’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-470,968
Closed -$9.83M 3314
2022
Q3
$9.83M Sell
470,968
-13,724
-3% -$286K ﹤0.01% 1478
2022
Q2
$10.1M Sell
484,692
-142,660
-23% -$2.54M ﹤0.01% 1507
2022
Q1
$10.6M Sell
627,352
-51,292
-8% -$897K ﹤0.01% 1606
2021
Q4
$13.6M Sell
678,644
-35,697
-5% -$672K ﹤0.01% 1501
2021
Q3
$13M Sell
714,341
-98,701
-12% -$2.26M ﹤0.01% 1599
2021
Q2
$22M Sell
813,042
-97,629
-11% -$2.73M 0.01% 1293
2021
Q1
$27.3M Sell
910,671
-317,350
-26% -$10.8M 0.01% 1094
2020
Q4
$35.3M Buy
1,228,021
+58,479
+5% +$1.58M 0.01% 890
2020
Q3
$28.5M Buy
1,169,542
+120,445
+11% +$2.6M 0.01% 854
2020
Q2
$18.8M Buy
1,049,097
+292,457
+39% +$3.84M 0.01% 1086
2020
Q1
$6.16M Buy
756,640
+280,434
+59% +$3.2M ﹤0.01% 1588
2019
Q4
$6.29M Buy
476,206
+296,060
+164% +$3.58M ﹤0.01% 1866
2019
Q3
$2.14M Sell
180,146
-20,699
-10% -$383K ﹤0.01% 2364
2019
Q2
$4.91M Buy
+200,845
New +$5.79M ﹤0.01% 2004

Other funds holding CVET

Nuveen's CVET Position: Q4 2022 in Review

Nuveen sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 470,968 shares — an estimated $9.83M sold.

Nuveen first reported a position in CVET in Q2 2019 and held it in 14 quarters. The position peaked at $35.3M in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Nuveen reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 470,968 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $9.83M.
  • Nuveen first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Nuveen's Covetrus, Inc. Common Stock position peaked at $35.3M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.